M. Hart

3.2k total citations
44 papers, 2.7k citations indexed

About

M. Hart is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, M. Hart has authored 44 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 16 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in M. Hart's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Complement system in diseases (9 papers) and Platelet Disorders and Treatments (6 papers). M. Hart is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Complement system in diseases (9 papers) and Platelet Disorders and Treatments (6 papers). M. Hart collaborates with scholars based in Netherlands, United Kingdom and United States. M. Hart's co-authors include Hans Pannekoek, C L Verweij, Gertjan Wolbink, Lucien A. Aarden, L Aarden, K. J. Stone, Diana Wouters, Just P. J. Brakenhoff, Theo Rispens and Dirk Roos and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and The EMBO Journal.

In The Last Decade

M. Hart

43 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Hart Netherlands	30	1.3k	560	518	481	400	44	2.7k
Federico Perosa Italy	25	1.0k 0.8×	430 0.8×	716 1.4×	359 0.7×	522 1.3×	93	2.4k
I. C. M. MacLennan United Kingdom	32	1.7k 1.3×	662 1.2×	556 1.1×	330 0.7×	437 1.1×	88	3.1k
C L Verweij Netherlands	25	1.3k 1.0×	229 0.4×	757 1.5×	589 1.2×	456 1.1×	33	2.9k
Brian V. Jegasothy United States	23	1.4k 1.1×	244 0.4×	355 0.7×	290 0.6×	443 1.1×	37	2.9k
P. C. Limburg Netherlands	29	956 0.7×	395 0.7×	490 0.9×	298 0.6×	234 0.6×	58	2.9k
Sharon Adams United States	24	1.5k 1.1×	226 0.4×	388 0.7×	507 1.1×	267 0.7×	66	2.3k
W. James Cook United States	30	1.2k 0.9×	262 0.5×	1.1k 2.2×	352 0.7×	589 1.5×	77	3.5k
Richard Aranda United States	20	1.3k 1.0×	366 0.7×	464 0.9×	654 1.4×	315 0.8×	37	3.2k
W.J.M. Tax Netherlands	26	1.7k 1.3×	985 1.8×	860 1.7×	220 0.5×	362 0.9×	77	2.7k
Eric H. Sasso United States	28	2.0k 1.6×	927 1.7×	698 1.3×	766 1.6×	291 0.7×	77	4.0k

Countries citing papers authored by M. Hart

Since Specialization

Citations

This map shows the geographic impact of M. Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hart more than expected).

Fields of papers citing papers by M. Hart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hart. The network helps show where M. Hart may publish in the future.

Co-authorship network of co-authors of M. Hart

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hart. A scholar is included among the top collaborators of M. Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hart. M. Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hart, M., Pleuni Ooijevaar‐de Heer, Karien Bloem, et al.. (2019). Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay. Science Translational Medicine. 11(477). 41 indexed citations

Schouwenburg, Pauline A. van, Simone Kruithof, M. Hart, et al.. (2014). Functional Analysis of the Anti-adalimumab Response Using Patient-derived Monoclonal Antibodies. Journal of Biological Chemistry. 289(50). 34482–34488. 54 indexed citations

Schie, Karin A. van, M. Hart, E R de Groot, et al.. (2014). The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region. Annals of the Rheumatic Diseases. 74(1). 311–314. 94 indexed citations

Mierlo, Geertje J. D. van, Nicole H.P. Cnubben, Diana Wouters, et al.. (2013). The minipig as an alternative non-rodent model for immunogenicity testing using the TNFα blockers adalimumab and infliximab. Journal of Immunotoxicology. 11(1). 62–71. 21 indexed citations

Schouwenburg, Pauline A. van, Lotte A van de Stadt, Rob N. de Jong, et al.. (2012). Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation. Annals of the Rheumatic Diseases. 72(1). 104–109. 157 indexed citations

Hart, M., Diana Wouters, Gertjan Wolbink, et al.. (2011). Differential effect of drug interference in immunogenicity assays. Journal of Immunological Methods. 372(1-2). 196–203. 130 indexed citations

Bartelds, G. M., Els de Groot, Michael T. Nurmohamed, et al.. (2010). Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study. Arthritis Research & Therapy. 12(6). R221–R221. 56 indexed citations

Brouwer, Nannette, F.N.J. Frakking, Marianne D. van de Wetering, et al.. (2009). Mannose-Binding Lectin (MBL) Substitution: Recovery of Opsonic Function In Vivo Lags behind MBL Serum Levels. The Journal of Immunology. 183(5). 3496–3504. 29 indexed citations

Till, J. W. Olivier van, Marja A. Boermeester, Piet W. Modderman, et al.. (2006). Variable Mannose-Binding Lectin Expression during Postoperative Acute-Phase Response. Surgical Infections. 7(5). 443–452. 20 indexed citations

10.

Brouwer, Nannette, Koert M. Dolman, Rob van Zwieten, et al.. (2006). Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Molecular Immunology. 43(13). 2051–2060. 46 indexed citations

11.

Bultink, Irene E. M., Dörte Hamann, Marc A. Seelen, et al.. (2006). Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 8(6). R183–R183. 35 indexed citations

12.

Wouters, Diana, M. Hart, Peter Bruins, et al.. (2005). Complexes between C1q and C3 or C4: Novel and specific markers for classical complement pathway activation. Journal of Immunological Methods. 298(1-2). 35–45. 34 indexed citations

13.

Mauray, Sandrine, Marie‐Thérèse Armentero, Grazia Nicoloso, et al.. (2000). Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6. European Journal of Immunology. 30(7). 2065–2073. 29 indexed citations

14.

Keul, Radovan, S Matern, M. Hart, et al.. (1996). Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. RWTH Publications (RWTH Aachen). 8 indexed citations

15.

Hart, M., et al.. (1996). Peritoneal Interleukin-8 in Acute Appendicitis. Journal of Surgical Research. 62(2). 273–277. 18 indexed citations

16.

Baars, Johanna W., Gertjan Wolbink, M. Hart, et al.. (1994). The release of interleukin-8 during intravenous bolus treatment with interleukin-2. Annals of Oncology. 5(10). 929–934. 11 indexed citations

17.

Verburgh, Cornelis A., M. Hart, LA Aarden, & A. J. G. Swaak. (1993). Interleukin-8 (IL-8) in synovial fluid of rheumatoid and nonrheumatoid joint effusions. Clinical Rheumatology. 12(4). 494–499. 30 indexed citations

18.

Deventer, Sander J. H. van, et al.. (1993). Endotoxin and Tumor Necrosis Factor-α-Induced Interleukin-8 Release in Humans. The Journal of Infectious Diseases. 167(2). 461–464. 53 indexed citations

19.

Hart, M., et al.. (1990). Fatty acids alter the susceptibility of cultured endothelial cells to oxidant injury. 1 indexed citations

20.

Brakenhoff, Just P. J., M. Hart, & L Aarden. (1989). Analysis of human IL-6 mutants expressed in Escherichia coli. Biologic activities are not affected by deletion of amino acids 1-28.. The Journal of Immunology. 143(4). 1175–1182. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact